Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to approximately 50 countries internationally.

Based in the UK, the brand was launched in 2005 by Charles Rolls and Tim Warrillow to provide high quality, natural mixers which could accompany the growing demand for premium spirits. The Group now sells a range of 12 differentiated flavours to hotels, restaurants, bars and cafes ("On Trade") as well as supermarkets and off-licenses for retail purchase ("Off Trade"). Approximately 70 per cent. of the Group's sales were derived from outside of the UK in FY13 with the key overseas markets being the US, Spain, and Belgium.

The Group's mixers are designed to be accompaniments for alcoholic spirits or used in cocktails, although they can also be consumed on their own. Since 2005, the Company has launched at least one new product a year, which includes 4 variants of tonic water, 2 variants of ginger beer, 3 variants of lemonade, and one variant each of ginger ale, soda water and cola.

7 November 2014
Admission to AIM and first day of dealings


http://www.fever-tree.com/

Very lengthy article in last weeks IC about investing in companies 'Looking at cash flows rather than profits'. Fevertree features heavily in the column as a company which has an ever increasing free cash flow. Lots of data included in the article concerning divi cover, capex ratios, free cash flow yield, cash flow margin & working capital but in summary "High quality, fast growing businesses such as FEVR are rarely available at a cheap price, but even after a significant share price fall over the past few weeks, FEVR still looks expensive on the basis of their free cash flow yield."
Much of the data is beyond me, but I was surprised to learn that "FEVR does not make or distribute it's products. These are outsourced to third parties. This means that the investment requirements of the business in manufacturing and distribution assets are nil."

so where's the bad news?

many people have been holding huge profits, and of course once this sort of share starts to tumble, it doesn't know where to stop, especially in the current climate

No bad news as such, it was just another way of choosing companies in which to invest. On the whole, the writer of the article (Phil Oakley) was pretty impressed with FEVR.

so am i :-)

Re post 652. It's Probably contagion Alf.

From yesterday :- Fevertree: Should you buy the correction or listen to alarm bells?

Appointment of Nomad and Joint Broker
RNS
RNS Number : 7836F
Fevertree Drinks PLC
31 October 2018

31 October 2018

Fevertree Drinks plc
("Fever-Tree" or the "Company")

Appointment of Nomad and Joint Broker
Fever-Tree, the world's leading supplier of premium carbonated mixers, announces the appointment of Numis Securities Limited as the Company's Nomad and Joint Broker with immediate effect.

falling without a break ...... no idea what is going on and certainly no news to trigger
perhaps a large holder steadily banking accumulated profits?

order book remains very weak, though without any real volume

Fevertree drinks are mighty expensive, DYOR about 4x similar volume of "Tesco Own" - given that many folk are going to mix them with something, the overall taste is probably all that matters. That saving can allow a little more strong-stuff to be added while not spending any more.
A good flavour should be at a premium, but just how much must be an issue.
When/If this stock pays a decent dividend. . ..
That could be a measure of their cash-generation / profits / etc. but at £25 is all hope IMHO.
EDIT (30Nov2018)-cynic, thanks for yr comments... whilst I don't doubt the flavours are "different", it's a bit like pop-songs... the one you hear first sets it in yr mind...so later singers somehow don't seem right. Perhaps drinks are the opposite(?), but you haven't dismissed the 4x price difference I mentioned.... hardly a few pennies on a bottle, methinks. There was a similar effect with those green bottles of French water.... until they had a problem.... then it was just an expensive water with food-miles....er, Cheers.

the taste of fevertree tonic - haven't tried the others - is very different even when mixed with spirits ..... personally, i am very happy to pay a few pennies more
similarly, different gins have different tastes

A good time to be taken over.

it did cross my mind that DGE was shorting with a view for a bid
be aware that DGE has been strong for several weeks

Copied from over the road.

Fevertree Bulls Return to Soothe Concerns Over Silent November

many thanks for that
an interesting read

Are you in UAE cynic? :-))

Blue-chip analysts tell investors to plough into Fevertree after recent sell-off
Share
13:11 30 Nov 2018
Jefferies still has its uber-bullish 4,300p price target in place, despite a sell-off, which has seen shares almost halve over the past three months

Fevertree’s rapid growth in its home UK market is beginning to normalise
Fevertree Drinks PLC (LON:FEVR) shares perked up on Friday after analysts at two major investment banks published bullish research notes, soothing investors who have had to nurse chunky losses in recent weeks.
The posh tonic maker was noticeably silent in November, a month when investors have become used to seeing a trading update telling them that full-year results will be well ahead of forecasts.

READ: Deutsche Bank expects Fevertree to lose its fizz in coming years
That, coupled with the wider equities sell-off, which has rocked stock markets of late, has seen Fevertree shares plunge from almost 4,000p in September to 2,400p now, wiping out all of 2018’s gains.
Morgan Stanley analyst Richard Felton reckons there is “still plenty of scope” for results to come in ahead of forecasts though.
Jefferies’ Ed Mundy also remains a fan and thinks the recent slump “offers an entry point into one of the most attractive growth stories in European beverages”, noting that management’s tone remains “confident”.
According to data from consumer insights group Nielsen, Fevertree’s growth has been slowing in recent months, although given the rapid growth seen over the past few years, Munday says a normalisation of growth “was always expected”.
His calculations suggest sales of Fevertree Drinks in the UK – which accounts for half of all revenue – could grow by up to 40-50% in the second half of this year.
The US will take over the reins as the AIM company’s growth driver over the next year or two and Mundy highlights the “good conditions” currently in place across the pond for Fevertree to enjoy a successful Stateside expansion.
The analyst repeated his blockbuster 4,300p price target and ‘buy’ recommendation.
Fevertree shares added 2.4% in early afternoon trading to 2,397p, still some way off September’s highs.

yes - a couple of fun-filled days ahead in ksa

:-))